ILF3 and neoplasm: In addition, gross images, HE and IHC staining also revealed that lefamulin alone or in combination with sorafenib/regorafenib treatment could reduce tumor densities, and accompanied by a lower level of Ki67‐positive cells and MRPL12 expression, but did not affect ILF3 expression (Figure 8D,E,H,I).